Designer Antibodies?

Antibodies responding to covid-19 coronavirus, illustration
Illustration of antibodies (y-shaped) responding to an infection with the new coronavirus SARS-CoV-2. The virus emerged in Wuhan, China, in December 2019, and causes a mild respiratory illness (covid-19) that can develop into pneumonia and be fatal in some cases. The coronaviruses take their name from their crown (corona) of surface proteins, which are used to attach and penetrate their host cells. Once inside the cells, the particles use the cells’ machinery to make more copies of the virus. Antibodies bind to specific antigens, for instance viral proteins, marking them for destruction by other immune cells, such as the macrophage white blood cell behind the virus.

DESIGNER ANTIBODIES!  A New Novel way to treat COVID-19!  Very interesting.  Actually, I do like this approach!  Now, let’s wait and see How the Trial Tests go…

I know the use of Plasma has had lukewarm results.  But hopefully this new Designer Antibodies will help everyone who has the Virus or as a Preventive as well.  I hope it works.

While the world is transfixed by the high-stakes race to develop a COVID-19 vaccine, an equally crucial competition is heating up to produce targeted antibodies that could provide an instant immunity boost against the virus.